95 related articles for article (PubMed ID: 12400570)
1. Medication errors. Liquid lansoprazole: gumming up the works.
Michael RC
Nursing; 2002 Oct; 32(10):14. PubMed ID: 12400570
[No Abstract] [Full Text] [Related]
2. Delivery of omeprazole and lansoprazole granules through a nasogastric tube in vitro.
Dunn A; White CM; Reddy P; Quercia RA; Chow MS
Am J Health Syst Pharm; 1999 Nov; 56(22):2327-30. PubMed ID: 10582827
[No Abstract] [Full Text] [Related]
3. Omeprazole and lansoprazole suspensions for nasogastric administration.
McAndrews KL; Eastham JH
Am J Health Syst Pharm; 1999 Jan; 56(1):81. PubMed ID: 10048885
[No Abstract] [Full Text] [Related]
4. On-demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazole.
Johnsson F; Moum B; Vilien M; Grove O; Simren M; Thoring M
Scand J Gastroenterol; 2002 Jun; 37(6):642-7. PubMed ID: 12126240
[TBL] [Abstract][Full Text] [Related]
5. Initial and chronic gastric acid inhibition by lansoprazole and omeprazole in relation to meal administration.
Brummer RJ; Geerling BJ; Stockbrügger RW
Dig Dis Sci; 1997 Oct; 42(10):2132-7. PubMed ID: 9365148
[TBL] [Abstract][Full Text] [Related]
6. An extensive metabolizer with recurrent ulcer responding to high dose of lansoprazole.
Higuchi K; Tanabe S; Koizumi W; Nakayama N; Sasaki T; Nagaba S; Saigenji K; Katada N
Hepatogastroenterology; 2004; 51(57):774-6. PubMed ID: 15143914
[TBL] [Abstract][Full Text] [Related]
7. Alternative method for administering proton-pump inhibitors through nasogastric tubes.
Peckman HJ
Am J Health Syst Pharm; 1999 May; 56(10):1020. PubMed ID: 10365730
[No Abstract] [Full Text] [Related]
8. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
Petite JP; Slama JL; Licht H; Lemerez M; Coste T; Andrieu J; Grimaud JC; Julien H; Dupuis J; Sallerin V
Gastroenterol Clin Biol; 1993; 17(5):334-40. PubMed ID: 8349067
[TBL] [Abstract][Full Text] [Related]
9. Which proton pump inhibitor should we use?
Williams CN
Can J Gastroenterol; 1997; 11(1):29. PubMed ID: 9113794
[No Abstract] [Full Text] [Related]
10. [Lansoprazole--profile of a new proton pump inhibitor].
Seifert E
Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
Takeda H; Hokari K; Asaka M
J Clin Gastroenterol; 1995; 20 Suppl 1():S7-9. PubMed ID: 7673616
[TBL] [Abstract][Full Text] [Related]
12. Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer.
Kovacs TO; Campbell D; Haber M; Rose P; Jennings DE; Richter J
Dig Dis Sci; 1998 Apr; 43(4):779-85. PubMed ID: 9558034
[TBL] [Abstract][Full Text] [Related]
13. Delayed-release lansoprazole plus naproxen.
Curran MP; Wellington K
Drugs; 2004; 64(17):1915-9; discussion 1920-1. PubMed ID: 15329041
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication.
Niv Y
Dig Dis Sci; 2005 May; 50(5):839-41. PubMed ID: 15906754
[TBL] [Abstract][Full Text] [Related]
15. Is short-term triple therapy with lansoprazole, clarithromycin, and metronidazole a definitive answer for Helicobacter pylori eradication?
Ozmen MM; Johnson CD
Am J Gastroenterol; 1995 Sep; 90(9):1542-3. PubMed ID: 7661197
[No Abstract] [Full Text] [Related]
16. Efficacy of lansoprazole in eradication of Helicobacter pylori.
Takimoto T; Ido K; Taniguchi Y; Satoh K; Saifuku K; Kihira K; Yoshida Y; Kimura K
J Clin Gastroenterol; 1995; 20 Suppl 2():S121-4. PubMed ID: 7594327
[TBL] [Abstract][Full Text] [Related]
17. The effects of oral doses of lansoprazole and omeprazole on gastric pH.
Tolman KG; Sanders SW; Buchi KN; Karol MD; Jennings DE; Ringham GL
J Clin Gastroenterol; 1997 Mar; 24(2):65-70. PubMed ID: 9077718
[TBL] [Abstract][Full Text] [Related]
18. Lansoprazole: an update of its place in the management of acid-related disorders.
Matheson AJ; Jarvis B
Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
[TBL] [Abstract][Full Text] [Related]
19. Acid control and regression of Barrett's esophagus: is the glass half full or half empty?
Castell DO; Katz PO
Am J Gastroenterol; 1997 Dec; 92(12):2329-30. PubMed ID: 9399786
[No Abstract] [Full Text] [Related]
20. Prevention of duodenal ulcer recurrence with 15 mg lansoprazole: a double-blind placebo-controlled study. The Lansoprazole Study Group.
Lanza F; Goff J; Silvers D; Winters J; Jhala N; Jennings D; Greski-Rose P
Dig Dis Sci; 1997 Dec; 42(12):2529-36. PubMed ID: 9440632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
